Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis.

Kvitko BH, Goodyear A, Propst KL, Dow SW, Schweizer HP.

PLoS Negl Trop Dis. 2012;6(6):e1715. doi: 10.1371/journal.pntd.0001715. Epub 2012 Jun 26.

2.

The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.

Norris MH, Propst KL, Kang Y, Dow SW, Schweizer HP, Hoang TT.

Infect Immun. 2011 Oct;79(10):4010-8. doi: 10.1128/IAI.05044-11. Epub 2011 Aug 1.

3.

A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists.

Propst KL, Mima T, Choi KH, Dow SW, Schweizer HP.

Infect Immun. 2010 Jul;78(7):3136-43. doi: 10.1128/IAI.01313-09. Epub 2010 Apr 19.

4.

Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection.

Propst KL, Troyer RM, Kellihan LM, Schweizer HP, Dow SW.

Antimicrob Agents Chemother. 2010 May;54(5):1785-92. doi: 10.1128/AAC.01513-09. Epub 2010 Feb 22.

5.

Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge.

Whitlock GC, Deeraksa A, Qazi O, Judy BM, Taylor K, Propst KL, Duffy AJ, Johnson K, Kitto GB, Brown KA, Dow SW, Torres AG, Estes DM.

Procedia Vaccinol. 2010;2(1). doi: 10.1016/j.provac.2010.03.013.

6.

Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand.

Trunck LA, Propst KL, Wuthiekanun V, Tuanyok A, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Peacock SJ, Keim P, Dow SW, Schweizer HP.

PLoS Negl Trop Dis. 2009 Sep 22;3(9):e519. doi: 10.1371/journal.pntd.0000519.

7.

Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis.

Troyer RM, Propst KL, Fairman J, Bosio CM, Dow SW.

Vaccine. 2009 Jul 16;27(33):4424-33. doi: 10.1016/j.vaccine.2009.05.041. Epub 2009 May 31.

8.

Vector design and development of host systems for Pseudomonas.

Schweizer HP, Hoang TT, Propst KL, Ornelas HR, Karkhoff-Schweizer RR.

Genet Eng (N Y). 2001;23:69-81. Review. No abstract available.

PMID:
11570107

Supplemental Content

Loading ...
Support Center